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estimated for approx. 70,000 (60,000 in males and 10,000 in 
females). For the aforementioned population, the mean loss of 
life span due to smoking was 21 years [4]. Currently in Poland, 
approximately 39% of adult males and 23% of adult females 
smoke cigarettes every day (according to research by Maria 
Skłodowska-Curie Memorial Cancer Centre and Institute of 
Oncology), among persons ≥40 years of age the percentage is 
34% and 22%, respectively [5]. Approximate estimates show 
that annual expenditures on treatment of smoking related dis-
eases in Poland amount to 18 billion PLN, and if prevalence of 
smoking does not change, the direct cost of treatment within 
20 years will increase to 198 billion PLN [6].
Smoking cessation brings substantial health benefits. 
A long -term observational study showed that smoking cessa-
tion at the age of 25–34 enables gaining 10 years of life in 
comparison with persons still smoking, and survival curves are 
similar to the ones of non-smoking males. Smoking cessation 
at the age of 35–44 is associated with life span extension by 9 
years in comparison with persons still smoking, at the age of 
45–54 – by 6 years, and at the age of 55–64 – by 3 years [7]. 
A systematic review of 20 prospective cohort studies showed 
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Summary: Objectives. The present paper discusses available data concerning the efficacy of non-pharmacological 
methods used in smoking cessation and describes the results of newly performed meta-analyses testing the  
12-month efficacy of these methods. This study is part of a more comprehensive program analyzing the efficacy 
and cost-effectiveness of different methods used in smoking cessation. Patients and methods. During the first 
stage of the study a systematic review of available data was made in order to identify methods used in smoking 
cessation and assess their efficacy on the basis of already existing reliable systematic reviews or meta-analyses.  
In the second stage of the study the efficacious and available in Poland methods (identified during the first stage by 
available data search and interviews with healthcare providers) were tested using new meta-analyses with the aim 
to define their efficacy in achieving at least the12-month continuous or prolonged abstinence. Results. The findings 
of the first stage of the study revealed that the reviews performed according to the Cochrane Collaboration 
methodology contained the most complete and up-to-date data. Meta-analyses of randomised controlled trials 
performed during the second part of the study showed that non-pharmacological smoking cessation methods 
available in Poland, namely the physician’s simple advice and individual and group counseling, increased the 
probability of smoking cessation and smoking abstinence for ≥12 months by 1.5 to 2 times and the number of 
patients who need to be treated to have one patient who stops smoking was about 30 for more intensive methods 
and 60 for the physician’s simple advice. Conclusions. The study confirmed that non-pharmacological smoking 
cessation methods available in Poland, i.e. the physician’s advice and individual and group counseling, increase the 
probability of smoking abstinence, and determined the 12-month effects of these interventions.
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INTRODUCTION
Smoking is a health problem of a considerable social signif-
icance on a global scale. It is estimated that there are over one 
billion adult smokers all over the world. Smoking is a cause of 
diseases leading to premature death and disability. Smoking, 
particularly cigarette smoking, is a predominant risk factor for 
lung cancer, as well as cardiovascular and respiratory system 
diseases (in particular chronic obstructive pulmonary disease 
[COPD]) [1-3]. 
Available data for the years 1990–1994 for the Polish pop-
ulation show that approx. 30% of deaths in males and approx. 
6% deaths in females were directly caused by smoking, whereas 
the total annual mortality attributable to smoking in Poland is 
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that smoking cessation, even among persons with already di-
agnosed ischemic heart disease, is associated with a reduction 
in death risk due to any cause (relative risk [RR] 0.64, 95% CI 
0.58–0.71), as well as in the risk of repeat of myocardial in-
farction (RR 0.68, 95% CI 0.57–0.82) [8].
In the reports concerning the situation of health care in 
Poland, published in recent years, attention was drawn to in-
sufficient, as compared with most of the industrialized coun-
tries, use of reliable information derived from scientific reports 
and economic analyses in the process of health policy planning 
and decision making in health care (e.g. in determination of 
list of reimbursed drugs) [9,10].
Reduction in smoking prevalence in Poland by intro ducing 
the interventions of confirmed efficacy into tobacco depen-
dence treatment, may be translated into reduction in morbi-
dity and mortality due to smoking related diseases, thus into 
reduction in costs of tobacco related diseases treatment.
Identification of methods used for tobacco dependence 
treatment (smoking cessation) based on systematic review and 
their efficacy analysis based on reliable scientific research, will 
make it possible to determine which of them could be of ben-
efit and should be applied on a wider scale.
PATIENTS	AND	METHODS
The objective of the study was to assess the efficacy and cost-
effectiveness of methods applied in tobacco dependence treat-
ment. Current report is dedicated only to analysis of efficacy of 
non-pharmacological methods used in smoking cessation.
Systematic review of data to identify  
the tobacco dependence treatment methods
The following electronic databases were searched (in alpha-
betical order): Addiction Abstracts, AMED, ASH (Action on 
Smoking and Health), ASSIA, BIDS-IBSS, CINAHL, Co-
chrane Library (Database of Cochrane Systematic Reviews 
and DARE), Conference Paper Index, CSA, Dirline, EIFL 
Direct, EMBASE, ERIC, Healthstar, Hstat, IBZ, IDEAL, ISI, 
MEDLINE via PubMed, ProQuest, PsycINFO, Science Direct, 
Sociological Abstracts, Springer Link, Swetsnet, applying the 
following keywords:
 – health problem: 1) smoking; 2) tobacco; 3) tobacco -use-
-disorder; 4) smok*; 5) cigaret*
 – intervention: 6) treatment; 7) treat*; 8) antismok*; 9) anti-
-smok*
 – outcome measure: 10) reduc*; 11) quit*; 12) stop*; 13) ab-
stin*; 14) abstain*; 15) smoking cessation; 16) tobacco-use-
-cessation
 – type of study: 17) systematic review; 18) meta-analysis; 
19) metaanalysis; 20) systematic review using “clinical que-
ries” option.
Search was limited to studies carried out on adults. Last 
search in the aforementioned databases was carried out in 
March 2004 and in the Cochrane Library in February 2005. 
At that stage, the efficacy of the identified methods in in-
creasing the probability of abstinence was assessed on the basis 
of the existing reliable systematic reviews and meta-analyses. 
Criteria of inclusion of a study in analysis
Systematic reviews or meta-analyses, where the efficacy 
was assessed based on randomized trials, were included in the 
efficacy analysis of non-pharmacological smoking cessation 
methods.
To be included in further analysis an intervention was re-
quired to have its efficacy, i.e. a significant difference in the 
percentage of persons remaining in continuous abstinence 
after at least 6 months from the beginning of therapy, shown 
in a reliable systematic review or meta-analysis.
Availability of individual tobacco dependence treatment 
methods in Poland was defined based on available data and 
interviews with health service providers.
Reliability assessment
The identified reports were initially screened for eligibility. 
After selection of the studies found, their reliability was ap-
praised in accordance with evidence-based medicine principles 
(EBM) based on special questionnaire drawn up in accordance 
with current criteria [11–19]. The critical appraisal form for 
systematic reviews and meta-analyses was prepared based on 
Critical Appraisal Skills Programme [11] and User’s Guide 
[12] questionnaires. 
The results of all the reviews were summarized, and the 
most up-to-date reliable systematic reviews were selected for 
further analysis.
Appraisal of efficacy in achieving 12-month 
abstinence
In the second stage of the study, for available in Poland 
and efficacious tobacco dependence treatment methods identi-
fied during the first stage, their impact on achieving at least 
12-month continuous abstinence (refraining from smoking 
from the moment of smoking cessation for the period of 12 
months; occasional slips/lapses are possible) or prolonged ab-
stinence (refraining from smoking from smoking cessation for 
12 months; during the first two weeks from the target date of 
smoking cessation, isolated slips/lapses are possible) was de-
fined by means of newly performed meta-analyses. Applica-
tion of data concerning the 12-month abstinence was associa-
ted with the fact that the available epidemiological data used 
in cost-effectiveness analysis and an economic model (risk of 
death and risk of disease) cover 12-month periods. Moreover, 
tobacco abstinence lasting at least one year provides a good 
chance of total success. 
Original studies, where the treatment efficacy was ex-
pressed as 12-month, continuous or prolonged tobacco absti-
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Table 1. Tobacco dependence treatment methods, which efficacy was assessed in the systematic reviews or meta-analyses found
Intervention Number of systematic reviews/meta-analyses  
(years of publication)
Cochrane review
Physician’s advice 2 (1997–2004) [24a,25] March 2004 [25]b
Nurse’s advice 1 (2004) [24a,26] June 2003 [26]b
Individual counseling 1 (2002) [27] The only review: February 2002 [27]
Group therapy 1 (2002) [28] The only review: December 2001 [28]
Aversion therapy / silver acetate 1 (2004) [29] / 1 (1997) [30] The only review: May 2004 [29]
The only review: May 1997 [30]
Hypnosis 1 (1998) [31] The only review: June 2001 [31]
Acupuncture 6 (1990–2002) [32-37] The only review: January 2002 [37]
Exercise 1 (2005) [38] The only review: August 2004 [38]
Bioresonance None None 
a Last searched May 1995
b The most complete and up-to-date search
nence (irrespective of the year of the study publication and the 
number of persons subjected to intervention) were extracted 
from reliable systematic reviews and meta-analyses, which 
were used for initial efficacy assessment; the studies, where 
abstinence was assessed only during the week preceding the 
medical control, were excluded. From individual studies, there 
were extracted numerical data covering the proportions of pa-
tients, who ceased smoking as a result of individual interven-
tions and remained abstinent for at least 12 months. For indi-
vidual types of interventions, the results of original studies were 
pooled by means of meta-analysis following Mantel-Haenszel 
procedure [20-23], using StatsDirect statistical package. The 
results were presecuted as pooled values of the abstinence pro-
portions both in the experimental and control groups, relative 
benefit, benefit difference, NNT (number needed-to-treat – 
the number of patients who need to be treated in order to have 
one patient who stops smoking) and 95% confidence intervals 
for those values. Statistical significance of the pooled results 
was calculated by means of the chi-square test, and homoge-
neity of results between the studies were examined by means 
of the Q test. 
RESULTS
During the first stage, systematic reviews and meta-
-analyses assessing the efficacy of non-pharmacological to-
bacco dependence treatment methods listed in Table 1 were 
found. 
The most complete and the most up-to-date data were in-
cluded in the reviews made in accordance with Cochrane Col-
laboration methodology. 
Among the non-pharmacological treatment methods, 
whose efficacy was unambiguously confirmed, the following 
are available in Poland: simple advice of a physician (short in-
tervention lasting ≤10 minutes, involving at most 1 additional 
follow-up visit), individual counseling (intensive intervention, 
lasting >10 minutes or involving ≥2 additional follow-up 
visits) and group therapy. 
1. Simple advice
Available reviews
Efficacy of simple advice (up to 10 minutes) in encouraging 
the smokers to give up smoking, in comparison with no advice, 
normal care or self-help materials was demonstrated in 3 sys-
tematic reviews. One of them assessed the efficacy of advice 
provided by physicians, nurses or other health care providers 
within the scope of primary health care (odds ratio [OR] 1.32, 
95% CI 1.18–1.48 [24]), one review assessed the efficacy of 
advice provided exclusively by physicians (OR 1.74, 95% CI 
1.48–2.05 [25]) and another one assessed the advice provided 
exclusively by nurses (OR 1.76, 95% CI 1.23–2.53 [26]).
Efficacy appraisal in achieving the 12-month 
abstinence
According to the information from the health service pro-
viders it was determined that in Poland simple advice is pro-
vided by physicians. Of 17 studies included in the most up-to- 
-date and reliable Cochrane systematic review [25], 8 studies 
assessing efficacy of simple advice provided by a physician in 
achieving 12-month abstinence were included in efficacy ana-
lysis (see webappendix). All the included studies were random-
ized controlled trials, where the patients of the control group 
did not receive any advice, only self-help leaflets and normal 
care or did not receive any treatment.
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The results of original studies included in the efficacy 
analy sis were pooled by means of meta-analysis and substan-
tial benefits of provision of the simple physician advice in com-
parison with no advice were observed (Tab. 2, Fig. 1). 
2. Individual counseling
Available reviews
In 3 systematic reviews, the efficacy of different types of in-
dividual counseling provided by a physician (OR 2.04, 95% CI 
1.71–2.43 [25]), a nurse (OR 1.43, 95% CI 1.24–1.64 [26]) or 
other health care providers (OR 1.62, 95% CI 1.35–1.94 [27]) 
was assessed in comparison with the control group, which was 
not provided with this kind of therapy.
Efficacy appraisal in achieving the 12-month 
abstinence
Of the aforementioned systematic reviews, further analysis 
covered randomized controlled trials, where the outcome mea-
sure was the 12-month abstinence: 8 studies concerning counsel-
ing provided by a physician, 2 concerning counseling provided 
by a nurse and 5 concerning counseling provided by different 
health care providers (see webappendix). In each study the pa-
tients in the control group were provided with simple advice.
The results of original studies included in the efficacy ana-
lysis were pooled by means of meta-analysis and substantial 
benefits were observed (Tab. 2, Fig. 2). 
3. Group therapy
Available reviews
Efficacy of different types of group psychotherapy in com-
parison with the control group receiving self-help materials or 
advice (OR 1.97, 95% CI 1.57–2.48) and in comparison with the 
control group not provided with any treatment (OR 2.19, 95% CI 
1.42–3.37) was demonstrated in one systematic review [28]. 
RB = 1.46 (95% CI 1.25–1.70)
Relative benefit (RB)

















RB for treatment with 95% CI CI out of scale
χ2 test = 23.3, df = 1, p <0.0001, Q test= 11.5, df = 14, p = 0.6 
Fig. 2. Efficacy of individual counseling in achieving 12-month ab-
stinence – relative benefit vs. simple advice. References – see web-
appendix. Abbreviations – see Fig. 1
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Relative benefit (RB)
Summary
RB for treatment with 95% CI
χ2 test = 22.2, df = 1, p <0.0001, Q test = 18, df = 7, p = 0.01
Fig. 1. Efficacy of simple physician’s advice in achieving 12-month 
abstinence – relative benefit vs. no advice. References – see web-
appendix. Abbreviations: df – degree of freedom
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Efficacy appraisal in achieving the 12-month 
abstinence
From the number of 24 studies included in systematic re-
view, 4 were included in the efficacy analysis, where the effica-
cy of group therapy in the 12-month abstinence was evaluated 
(see webappendix). All the included studies were randomized 
controlled trials, where the patients of the control group were 
provided with simple advice and in some studies also with self- 
-help leaflets.
The results of original studies included in the efficacy 
analy sis were pooled by means of meta-analysis and substan-
tial benefits of group therapy in comparison with simple ad-
vice were observed (Tab. 2, Fig. 3). 
4. Other non-pharmacological methods  
of treatment
Available reviews
The systematic reviews or meta-analyses found did not un-
ambiguously showed the efficacy of the following non-phar-
macological methods:
 – aversion therapy and silver acetate (aversion therapy con-
sists of simultaneous application of positive [smoking] 
and negative reinforcement [e.g. quick smoking of a large 
number cigarettes and simultaneous concentration on un-
pleasant impressions or application of silver acetate, which 
produces unpleasant taste] to create a new conditioned re-
sponse and thus modified behavior) [29,30]
 – hypnosis [31]
 – acupuncture [32-37]
 – exercise [38].
Systematic reviews, meta-analyses or randomized control-
led trials concerning the effectiveness of so-called bioresonance 
in tobacco dependence therapy were not found [39,40].
DISCUSSION
The analysis of systematic reviews and meta-analysis of 
randomized controlled trials assessing the non-pharmacologi-
cal tobacco dependence treatment methods demonstrated ef-
ficacy of the methods available in Poland, viz. the physician’s 
simple advice, individual counseling and group therapy, in in-
creasing the probability of the 12-month tobacco abstinence. 
For all the aforementioned methods, the probability of smok-
ing cessation in comparison with the control group increased 
approx. by 1.5 to 2 times. However, the number of patients 
who need to be treated in order to have one patient who stops 
smoking (NNT) for the physician’s simple advice in compari-
son with no-advice was 60, and for individual counseling and 
group therapy in comparison with simple advice it was 36 and 
31, respectively. The results of the study are consisted with the 
results of other studies and with guidelines for tobacco depen-
dence treatment [41-44]. 
There is, therefore, the possibility of effective influence 
on smoking cessation showed by scientific research. However, 
according to information provided by individual departments 
of the National Health Fund (Narodowy Fundusz Zdrowia – 
NFZ) or via their websites in 2004, nicotine dependence clinic 
services (code 1742) were contracted only in 5 NFZ depart-
ments. Moreover, smoking advice is one of the components 
of the cardiovascular disease prophylaxis program and the 
COPD prophylaxis program currently being contracted in 
most of NFZ departments. 
Apart from non-pharmacological interventions, there are 
also effective pharmacological methods of tobacco dependence 
treatment, like nicotine replacement therapy, bupropion or va-
renicline, recently released on the market. Their addition to 
non-pharmacological methods results in higher probability of 
smoking cessation than when applying non-pharmacological 
methods alone, and NNT ranges from 6 to 21. However, their 
application cost for the patient is higher, especially as those 
drugs are not reimbursed (in the year 2004, cost of simple 
advice was estimated at ca. 7 PLN/day, and that of pharmaco-
logical treatment at ca. 10 PLN/day) [45].
Smoking cessation is associated with the reduction in risk 
of death and morbidity due to tobacco related diseases, there-
fore, it seems justifiable to introduce a systematic approach 
to treatment of this dependence using the methods of con-
firmed effectiveness and, at the same time, to provide informa-
tion concerning the effectiveness or ineffectiveness of various 
methods both to physicians and, first of all, to patients. 
”Konsensus dotyczący diagnostyki i leczenia zespołu 
uzależnienia od tytoniu” drawn up by multidisciplinary team 
of specialists and published in 2006 [44] states that treatment 
of tobacco dependence is a physician’s obligation and he should 
RB = 2.08 (95% CI 1.43–3.04)
Relative benefit (RB)






RB for treatment with 95% CI
χ2 test = 14.4, df = 1, p = 0.0001, Q test = 3.1, df = 3, p = 0,4
Fig. 3. Efficacy of group therapy in achieving 12-month abstinence 
– relative benefit vs. simple advice. References – see web appendix. 
Abbreviations – see Fig. 1
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The second aspect raised in the presented study is assess-
ment of possibility of broader use of reliable information from 
scientific reports in the process of health policy planning and 
in health care decision making, both at the level of central 
authorities, and at the lowest level, i.e. in a surgery. In most 
of the tobacco dependence treatment methods, the most up- 
-to-date and reliable, and usually the only source of informa-
tion, was the systematic review published in the Cochrane 
Library, which is currently available free of charge for every-
one in Poland (Medical Technology Assessment Agency, web-
site: www.aotm.gov.pl). The Medical Technology Assessment 
Agency was established by the directive of the Minister of 
Health of 30 June 2006 [52]. Its establishment boosts hope for 
still broader use of scientific evidence in health care decision 
making in Poland (according to EBM principles). Drawing up, 
verification, collection, making available and dissemination of 
information about assessment of medical technology made in 
the Republic of Poland and other countries and production 
of recommendations concerning medical technology for the 
minister in charge of health are among its objectives. 
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